Trust our pharmaceutical lactose

Discover Lactalis Ingredients Pharma: Your Trusted Partner in Pharmaceutical Lactose

Embark on a journey with Lactalis Ingredients Pharma and explore Lactalpha, our reliable range of milled and sieved pharmaceutical grade lactose monohydrate for your OSD applications.

Our range includes:

  • Lactalpha 150: 150 mesh milled lactose.
  • Lactalpha 100: 100 mesh milled lactose.
  • Lactalpha 50: 50 mesh sieved lactose.

Lactalpha is manufactured in France, conforming to the monographs of the current Pharmacopoeias (Ph. Eur., USP-NF and JP) ensuring consistent quality. 

As a part of the Lactalis Group, a prominent leader in the dairy industry, Lactalis Ingredients Pharma benefits from an extensive and reliable supply of raw liquid whey, ensuring a consistent availability of pharmaceutical lactose. Lactalis Ingredients Pharma is also committed to sustainability, focusing on water resource preservation and reducing carbon emissions, making us a reliable and trusted partner. 

Learn more about us and explore our range on our website.
Contact our team to request a sample.

Go to article: Home | Enhancing therapy adherence with prodrugsGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: CytivaGo to article: NiproGo to article: Laboratorios Argenol Company InsightGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Avenga Company InsightGo to article: Lactalis IngredientsGo to article: BSP PharmaceuticalsGo to article: AlfatestLABGo to article: Alphial Company InsightGo to article: In DepthGo to article: Prodrugs and patents: Enhancing therapy adherence and reducing side effectsGo to article: Are PBMs to blame for high drug prices in the US?Go to article: Into the unknown: how quickly can vaccines be developed for Disease XGo to article: US negotiations for first round of drugs reveal $6bn in Medicare savings Go to article: Emerging microbiome market – unlocking new frontiers Go to article: Build or buy? Key considerations for in-house manufacturingGo to article: BiomeBank Company InsightGo to article: IMP Pharmaceutical ServicesGo to article: XylemGo to article: Sponsored SupplementsGo to article: Techniconsult Firenze Company InsightGo to article: PfanstiehlGo to article: Duoject Medical Systems Company InsightGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Innovation RankingsGo to article: Buyer's GuidesGo to article: Zenatek Company InsightGo to article: BEA TechnologiesGo to article: Next issue